bevacizumab

bevacizumab

美 　英

• 網絡貝伐單抗；貝伐珠單抗；貝伐株單抗

例句

"Our hope now, " he added, "is to see greater improvement by using bevacizumab at earlier stages of the disease. "

他補充說：“我們的希望是看到在疾病早期用貝伐單抗就能顯著改善患者病情。”

In the phase II study, the rate of life-threatening and fatal pulmonary hemorrhages had been increased with bevacizumab treatment (9. 1%).

在II期研究中，貝伐單抗治療導致的致命率和致死性肺出血就已經增加（9.1%）。

Patients taking higher dosages of bevacizumab had the greatest risk of developing proteinuria.

接受更高劑量的貝伐單抗的患者有更大的患蛋白尿的風險。

Bevacizumab treatment was associated with a low rate of serious adverse events.

貝伐單抗治療嚴重不良事件率很低。

Bevacizumab, a recombinant humanized anti-VEGF monoclonal antibody, has proven beneficial to cancer therapy.

貝伐單抗為重組人源化抗VEGF的單克隆抗體，其治療腫瘤具有良好的效果。

ObjectiveTo evaluate the efficacy and safety of bevacizumab plus capecitabine in treating metastatic colorectal cancer(mCRC).

目的觀察貝伐單抗聯合卡培他濱治療轉移性結直腸癌的療效及不良反應。

The use of bevacizumab (as well as cetuximab) for maintenance remains unproven, however.

貝伐單抗（以及西妥昔單抗）對維持治療仍無提高。

This trial provides level-one evidence for the use of bevacizumab injections for the treatment of wet AMD, they conclude.

他們得出結論，這項試驗提供了貝伐單抗注射用于治療濕性老年黃斑變性AMD一級證據。

Avastin, the trade name of bevacizumab, is marketed by Swiss pharmaceutical giant Roche.

阿瓦斯丁是貝伐單抗的商品名，這種藥由瑞士羅氏制藥企業在市場上出售。

At one point Avastin, also called bevacizumab, seemed a shoo-in to be approved for breast cancer.

從治療效果來講，阿瓦斯汀，又被稱為貝伐單抗，似乎呼聲很高地被批準成為乳腺癌治療用藥。

Bevacizumab is a medication that helps your body fight cancer .

貝伐單抗是一種藥，有助于身體對抗癌癥。

So if we go back, for example, to the drug bevacizumab in connection with advanced breast cancer. . .

因此，讓我們回到抗癌藥物上來，例如，晚期乳腺癌的藥物-貝伐株單抗。

Adverse reactions to bevacizumab and its combination with chemotherapy regimen

貝伐單抗及其聯用化療方案的不良反應

Assessment of the Efficacy and Safety of Bevacizumab Plus Carboplatin and Paclitaxel in Patients with Non-Small Cell Lung Cancer

貝伐單抗聯合卡鉑加紫杉醇在非小細胞肺癌中的療效與安全性評價